Inflammatory

Engineered Flt3L Variants For Antigen Tolerance Induction

SUMMARY Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need: Novel technologies to modulate the immune system to induce tolerance against therapeutic proteins… Read More